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Labor Management Protocol for Parturients on Buprenorphine
Erik Sanders BSN, RN
Executive Summary
Introduction of the Problem
Opioid dependence in the US has reached epidemic levels (Reddy, Davis, Ren & Greene,
2017). Opioid dependence during pregnancy may lead to negative outcomes for both the
parturient and the fetus. Women with known opioid dependence are often prescribed drugs such
as methadone, or more recently, buprenorphine. Buprenorphine, an opioid, is a partial mu
receptor agonist prescribed by providers as a form of medication assisted therapy (MAT) for
opioid addiction and chronic opioid use (Reddy et al., 2017). The use of buprenorphine within
parturients is a relatively new practice and anesthesia providers are encountering difficulties in
managing this population during the peripartum period. The lack of a comprehensive,
standardized approach for pain management during the peripartum period for the parturient on
buprenorphine therapy has created many challenges for anesthesia providers. Given the
increasing number of opioid dependent parturients, the creation of effective pain management
regimen for this group is a priority. A Midwestern tertiary care center does not have a protocol
for the care of parturients on buprenorphine therapy, and anesthesia providers and obstetricians
desire the development of an organized plan for the care of this population.
Literature Review
The goal of pain management in this patient population is to effectively manage the
intrapartum period to improve patient satisfaction and outcomes, reduce the overall cost of their
health care, decrease the length of stay, and promote maternal-child bonding postpartum.
Women are encouraged to continue their MAT while pregnant. Abruptly stopping treatment can

lead to ill outcomes, including intractable pain and opioid withdrawal symptoms (Souzdalnitski
& Snegovskikh, 2014). Pain management strategies should be formulated based upon the clinical
and psychological presentation of the parturient with clear and realistic goals (Pan & Zakowski,
2017).
The use of regional anesthesia during the anesthetic period is an acceptable source of
analgesia and is preferable to systemic opioid use (Pan & Zakowski, 2017; Park, Meltzer-Brody
& Suzuki, 2012). Alto & O’Connor (2011) noted that non-opioid analgesics may be sufficient for
post-vaginal delivery pain, but opioids should be available if the pain to becomes more severe.
Patient controlled analgesia (PCA) is an option for the acute management of breakthrough pain
in this population after a cesarean (Jones et al., 2008; Meyer et al., 2010; Reddy et al., 2017).
There are, however, certain drugs which should be avoided when providing analgesia for
parturient taking buprenorphine. Drugs such as nalbuphine and butorphanol are mixed opioid
agonist-antagonist drugs. Thus, a parturient who receives one of those drugs may develop
withdrawal symptoms related to the opioid antagonist component of the medication (Jones, et al.,
2008; Reddy et al., 2017).
Project Methods
The purpose of this project was to create a labor pain management protocol for
parturients on buprenorphine at a Midwestern tertiary care center. The main goal of the project
was to perform a thorough literature review related to the peripartum management of women
taking buprenorphine and subsequently disseminate those findings in the form of a PowerPoint
presentation to primary stakeholders in the anesthesia and obstetrics departments. Prior to
implementation, the project’s proposal was submitted for evaluation and deemed exempt by
Southern Illinois University Edwardsville’s Institutional Review Board (IRB).

Evaluation
The primary outcome measured for this project was the multidisciplinary team’s
knowledge of buprenorphine after the presentation. A true/false questionnaire aimed at
evaluating the author’s effectiveness in teaching the team members about buprenorphine was
distributed at the conclusion of the presentation. Of the staff members in attendance, six returned
surveys. Several members of a typical parturient’s care team were represented, including two
nurse anesthetists, two obstetrical nurses, a pharmacist, as well as a maternal/fetal medicine
physician. All respondents correctly identified that buprenorphine is an opioid agonistantagonist. Only half of the participants correctly identified that Suboxone was not the correct
trade name for buprenorphine (Subutex). All participants correctly noted that ACOG
recommends continuing buprenorphine throughout the peripartum period. The majority of
respondents (5/6; 89%), recognized that neonatal abstinence syndrome is a potential
complication of buprenorphine therapy. All participants understood that parturients on
buprenorphine may receive neuraxial analgesia. All respondents correctly indicated that
parturients on buprenorphine may exhibit hyperalgesia and also have a 47% increase in opioid
requirements post cesarean-section. Finally, all respondents noted that Nubain and Stadol were
not good analgesic options for this population.
Included at the conclusion of the questionnaire was a five-point Likert scale gauging the
degree of support for a labor management protocol at the host facility. The mean score was a
4.67/5, indicating strong support and a recognized need for a labor management protocol for
parturients on buprenorphine therapy.
One major limitation faced by this project was the small sample size. The number of
participants was directly related to high workload in the operating room and labor unit the day of

the presentation. As such, the results of the questionnaire may not be generalizable to a larger
number of respondents due to a small sample size. Another limitation of the project is the lack of
evidence available from the literature review. Few studies exist detailing pain management for
parturients on buprenorphine during the peripartum period and no example pain management
protocols for the parturient population were discovered during the literature search.
Impact on Practice
Results of the survey indicated that the educational presentation created a strong level of
support for the introduction of a pain management protocol for parturients on buprenorphine.
The immediate impact of this project at the institution was a greater awareness of parturients on
buprenorphine therapy. Another immediate impact was an increase in communication between
the anesthesia department and maternal/fetal medicine practitioners when managing parturients
on buprenorphine. This protocol could create a powerful impact over the long-term for
parturients once fully implemented. A labor pain management protocol could improve
maternal/fetal outcomes, decrease length of stay, and improve patient satisfaction.
Conclusion
Limited data exists regarding peripartum pain management for the parturient on
buprenorphine therapy. There is no universal guideline to aid anesthesia providers in the
peripartum management of parturients undergoing MAT with buprenorphine. As there are a lack
of studies, most pain management recommendations for this population are made from case
reports and provider opinion (Anderson, et al., 2017). As such, pain management strategies
should be individualized, include multimodal analgesic options including oral, intravenous and
neuraxial techniques, and be based on the collaborative efforts of the parturient, obstetrician,
nurses, and anesthesia providers. The results of this project indicate that anesthesia providers and

labor and delivery nurses at this facility were in favor of implementing a labor management
protocol for parturients on buprenorphine. It can be concluded that the availability of such
protocol may have a significant impact on the anesthesia providers, as well as the parturients in
their care.
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